Evaluation of mass drug administration under the National Vector Borne Disease Control Program for lymphatic filariasis elimination in rural area of Telangana: A community-based cross-sectional study
Background: In 2021, the World Health Organization (WHO) estimates that globally, about 884.9 million individuals were at risk of lymphatic filariasis (LF) and 28 countries reported having treated a total of 364.9 million people (41.2%). In India, LF presents a major public health concern, affecting...
Saved in:
| Main Authors: | Ratna Balaraju, Chandrasekhar Vallepalli, Chandra Sekhar Kalevaru, MMV Prasad Sharma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | MRIMS Journal of Health Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/mjhs.mjhs_76_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mass drug administration to eliminate lymphatic filariasis: A population-based coverage and compliance study in Eastern India
by: Shubhashisha Mohanty, et al.
Published: (2024-11-01) -
Coverage and evaluation survey of post-mass drug administration for lymphatic filariasis in four endemic districts of Uttar Pradesh: Are we on the track?
by: Sourabh Paul, et al.
Published: (2025-04-01) -
Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study
by: Muhammed Jabir, et al.
Published: (2024-11-01) -
Lymphatic filariasis elimination in Kenya: Tracing the journey from 2002-2024 and pathways to achieving 2030 target
by: Michael Ofire Ofire, et al.
Published: (2025-03-01) -
Brazil was certified by the World Health Organization for having eliminated lymphatic filariasis: what now?
by: Eduardo Brandão, et al.
Published: (2025-03-01)